Download IntersectDX Executive Summary

Global Demand for Personalized Therapies, Technological Innovation

0B
$217B Global Precision Medicine Market by 2028 – 10%CAGR
0B
$118B Global Biomarker Market by 2026 – 14%CAGR
0B
$20B Global Cancer Biomarker Market by 2022 – 12%CAGR
0B
$1B Market for Spatial Discovery Tools by 2025
0%
Drugs in Development That Include Biomarkers in Their Design
0B
Sponsor Spend on CRO Services in 2018, Surpassing Spend on Internal Infrastructure by $20B

Significant Deal Activity for Precision Medicine Companies

2018 M&A = $2.7B

2018 VC = $233M

2019 M&A = $525M

2019 VC = $350M

Discover With Precision

Advancing biomarker signature discovery for precision therapeutics

Contact Us